|
Wisconsin Pharmaceutical Research & Development News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about Wisconsin Pharmaceuticals.
Latest Wisconsin Pharmaceutical Research & Development News
- Abbott Labs sues Teva 21 Nov 2009 15:13 GMT
... LIBERTYVILLE TOWNSHIP - Abbott Laboratories sued Teva Pharmaceutical Industries Ltd., the world's largest generic-drug maker, to prevent it from marketing copies of the ... Abbott and patent partner the Wisconsin Alumni Research Foundation contend Israel's Teva plans to begin ...
- NIGMS 'Challenge' Areas Get Millions in Recovery Act Funds 21 Nov 2009 04:32 GMT
... Act) funds to jump-start a range of research projects that address critical gaps in the ... of Emory University in Atlanta ($852,500) to develop a model organism — the prairie vole ... environmentally friendly methods for developing and producing pharmaceuticals. Hierarchical Spatial Process Models for Estimating and ...
- CombiMatrix Corporation Reports Third Quarter 2009 Financial Results 21 Nov 2009 09:12 GMT
... company's Comprehensive Cancer Array test currently in development "CombiMatrix continued to solidify its position as ... the comparable 2008 period. Operating expenses included research and development and marketing, general and administrative ... a Sales Manager with Johnson & Johnson's pharmaceutical division and has since spent more than ...
- Escalon(R) Reports First Quarter Fiscal 2010 Results 21 Nov 2009 01:11 GMT
... and Medical/Trek, respectively, for the same period. Research and development decreased 58.7%, 39.7%, and 33.3% at Drew, ... markets and distributes ophthalmic diagnostic, surgical and pharmaceutical products as well as vascular access devices. ...
- Memory Loss Screening Encouraged by Maker of Brain Nutrition Supplement Prevagen 21 Nov 2009 16:55 GMT
... researcher Mark Underwood, president of the Madison, Wisconsin-based biotech company, Quincy Bioscience, maker of Prevagen. ... by qualified healthcare professionals including social workers, pharmacists, physician assistants, nurse practitioners, and physicians that ... Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight ...
- Report on complex IP landscape that affects development of human embryonic stem cell products 18 Nov 2009 10:13 GMT
... of all stem cell types and can develop into over 200 different cell types of ... the University of Wisconsin, the Wisconsin Alumni Research Foundation (WARF) filed a series of landmark ... has also been in control of what pharmaceutical companies have been able to develop hESC ...
- Research and Markets: An Essential Report on the Opportunities in Human Embryonic Stem Cell (hESCs) Products 17 Nov 2009 12:50 GMT
... Research and Markets: An Essential Report on the ... of all stem cell types and can develop into over 200 different cell types of ... has also been in control of what pharmaceutical companies have been able to develop hESC ...
- John Emanuele, Ph.D., Joins Baker & Daniels Intellectual Property Law Group 19 Nov 2009 00:14 GMT
... and international patent applications in the chemical, pharmaceutical and biotechnology arts. Besides filing patent applications, ... his law degree from the University of Wisconsin Law School in 2002, his Ph.D. in ... worked in the corporate sector as a research scientist in the bio-energy, pharmaceutical, food flavor ...
- Revised: 20 Ways Antihealth Departments Kill, Steal, and Abuse 20 Nov 2009 20:17 GMT
... Abuse Health Departments are servants of the drug company pawns of the CDC, of the meat ... clinics. Instead, health officials bow to the pharmaceutical hospital doctor insurance industrial complex. 4 Food ... health departments enable the engorging of international drug companies in concert with the drug company dominated ...
- Study Raises Questions About Cholesterol Drug's Benefit 16 Nov 2009 16:26 GMT
... Study Raises Questions About Cholesterol Drug’s Benefit Published: Monday, ... has been investigating the conduct of two drug makers, Merck and Schering-Plough, in relation to their sales ... Peter S. Kim, the president of Merck Research Laboratories, said Sunday in an interview that ...
- Let desperate patients have pot 19 Nov 2009 15:38 GMT
... marijuana as a controlled substance so more research on marijuana-based medicines can occur. Doctors already ... If that's too ripe for abuse, a drug company could grow the drug and dispense it through ... and dispense it through medical professionals or pharmacies. Gov. Jim Doyle announced his support for ...
- Study raises questions about Zetia pill 16 Nov 2009 02:04 GMT
... A new study raises fresh concerns about Zetia and its ... consultants to the company or to rival drug makers. Researchers enrolled 363 people with heart disease or ... are not fully understood, he said. Merck's research chief, Peter Kim, said the study and ...
- UW-Madison Major Gifts and Contributions Since 1988 17 Nov 2009 19:16 GMT
... donates $3 million to the University of Wisconsin-Madison for its retail center. The gift will ... $1.3 million to the UW-Madison for influenza research to be conducted with a Lentigen Corp., ... donates $1 million to the Lenor Zeeh Pharmaceutical Experiment Station at UW-Madison's School of Pharmacy. ...
- Opportunities in Human Embryonic Stem Cell (hESC) Products 17 Nov 2009 09:31 GMT
... Stem Cell (hESC) Products" which gives the development of human embryonic stem cell products. Opportunities ... the University of Wisconsin, the Wisconsin Alumni Research Foundation (WARF) filed a series of landmark ... has also been in control of what pharmaceutical companies have been able to develop hESC ...
- November is National Diabetes Month. Gurnee Dentists Dr. Ira L Shapira and Dr. Mark Amidei Blend Med 18 Nov 2009 13:32 GMT
... School in the 1980's where he did research on the relation of jaw position in ... what proportion of these individuals will eventually develop clinical disease or be at risk for ... airway collapsibility. This suggests that electrical or pharmacological stimulation of the upper airway musculature might ...
Powered by 
Wisconsin Pharmaceuticals News Sections
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
- CDC Reverses Gardasil Vaccine Requirement for Immigrants [21 Nov 2009 - 03:15]
- FDA actions in brief, November 2009 (FluMist, Cervarix, Gardasil, Fluarix, Folotyn, Micardis, Twynsta, Votrient, Mirena) [20 Nov 2009 - 17:02]
- FDA Pipeline preview, October 2009 (Eplivanserin, Pancrelipase, Trabectedin, Clofarabine, Fampridine-SR, Collagenase clostridium histolyticum, Oxycodone reformulated, Pegylated interferon alfa-2b, Maraviroc, Armodafinil, R [20 Nov 2009 - 17:02]
- Pregnancy, not nevirapine cause of liver toxicities in HIV-positive women [20 Nov 2009 - 04:58]
- FDA Approves Gardasil for Genital Warts in Men and Boys [19 Nov 2009 - 16:02]
Pharmaceutical Industry Today
|
a digital news provider
>
Pharmaceutical Research & Development
reuters.com:
healthday.com: